In Vitro Test Validation and Regulatory Animal Testing: A House Built on Sand versus a House of Cards?

Flint O.P. (1992). In vitro test validation: a house built on sand. ATLA 20, 196–198.

Balls M. , Blaauboer B. , Brusick D. , Frazier J. , Lamb D. , Pemberton M. , Reinhardt C. , Roberfroid M. , Rosenkrantz H. , Schmid B. , Spielmann H. , Stammati A-L. , & Walum E. (1990). Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. ATLA 18, 313–317.

Peloux A.F. , Federici C. , Bichet N. , Gout D. , & Cano J-P. (1992). Hepatocytes in primary culture: an alternative to LD50 testing? Validation of a predictive model by multivariate analysis. ATLA 20, 8–26.

Kruszewski F.H. , Hearn L.H. , Smith K.T. , Teal J.J. , Gordon V.C. , and Dickens M.S. (1992). Application of the EYTEX™ system to the evaluation of cosmetic products and their ingredients. ATLA 20, 146–163.

Gettings S.D. , Teal J.J. , Bagley D.M. , Demetrulias J.L. , DiPasquale L.C. , Hintze K.L. , Rozen M.G. , Weise S.L. , and Kurtz P.J. (1991). The CTFA Evaluation of Alternatives Program. An evaluation of in vitro alternatives to the Draize Primary Eye Irritation Test. (Phase I) Hydroalcoholic formulations; (Part 2) data analysis and biological significance. In Vitro Toxicology 4, 247–288.

Green S. (1987). Regulatory issues associated with use of alternative tests. In Advances in Modern Environmental Toxicology, Vol. 10 (ed. Mehlman M.A. ), pp. 107–116. Princeton, NJ: Princeton Scientific.

Balls M. (1992). In vitro test validation: high-hurdling, but not polevaulting. ATLA 20, 355–357.

Balls M. , and Fentem J.H. (1992). The use of basal cytotoxicity and target organ toxicity tests in hazard identification and risk assessment. ATLA 20, 368–388.

Lehman-McKeeman L.D. , and Caudill D. (1992). Biochemical basis for mouse resistance to hyaline droplet nephropathy: lack of relevance of the o.2u-globulin protein superfamily in the male rat-specific syndrome. Toxicology and Applied Pharmacology 12, 213–221.